Engineering Biomaterials for Enhanced Tissue Regeneration

Current Stem Cell Reports

Volumn 2, Issue 2, 2016, Pages 140-146

  Abbott, Rosalyn D ^a   Kaplan, David L ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Biodegradable; Biomaterial; Scaffold; Tissue engineering; Tissue regeneration

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; ELASTIN; POLYGLACTIN; POLYLACTIC ACID;

BIOMECHANICS; BIOMINERALIZATION; CELL ADHESION; CELL DIFFERENTIATION; CELL INFILTRATION; DEGRADATION KINETICS; ENCAPSULATION; HUMAN; ORGAN CULTURE; POROSITY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; THREE DIMENSIONAL PRINTING; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE SCAFFOLD;

EID: 84986563325     PISSN: None     EISSN: 21987866     Source Type: Journal    
DOI: 10.1007/s40778-016-0039-3     Document Type: Review

References (54)

1. Murphy CM, O’Brien FJ. Understanding the effect of mean pore size on cell activity in collagen-glycosaminoglycan scaffolds. Cell Adhes Migr. 2010;4(3):377–81.
2. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260(5110):920–6.
3. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005;26(27):5474–91.
4. Xu C et al. Triggerable degradation of polyurethanes for tissue engineering applications. ACS Appl Mater Interfaces. 2015;7(36):20377–88.
5. Chen RR, Mooney DJ. Polymeric growth factor delivery strategies for tissue engineering. Pharm Res. 2003;20(8):1103–12.
6. Hersel U, Dahmen C, Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials. 2003;24(24):4385–415.
7. Chan BP, Leong KW. Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur Spine J. 2008;17 Suppl 4:467–79.
8. Sung HJ et al. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials. 2004;25(26):5735–42.
9. Lasprilla AJR et al. Poly-lactic acid synthesis for application in biomedical devices—a review. Biotechnol Adv. 2012;30(1):321–8.
10. Kundu B et al. Silk proteins for biomedical applications: bioengineering perspectives. Prog Polym Sci. 2014;39(2):251–67.
11. Langer R, Tirrell DA. Designing materials for biology and medicine. Nature. 2004;428(6982):487–92.
12. Brown BN, Badylak SF. Extracellular matrix as an inductive scaffold for functional tissue reconstruction. Transl Res. 2014;163(4):268–85.
13. Schella JY et al. Harnessing cellular-derived forces in self-assembled microtissues to control the synthesis and alignment of ECM. Biomaterials. 2015;77:120–9.
14. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005;23(1):47–55.
15. Engler AJ et al. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126(4):677–89.
16. Weadock K, Olson RM, Silver FH. Evaluation of collagen crosslinking techniques. Biomater Med Devices Artif Organs. 1983;11(4):293–318.
17. Xiao S et al. Mechanical response of silk crystalline units from force-distribution analysis. Biophys J. 2009;96(10):3997–4005.
18. Xu HH et al. Effects of incorporating nanosized calcium phosphate particles on properties of whisker-reinforced dental composites. J Biomed Mater Res B Appl Biomater. 2007;81(1):116–25.
19. Vozzi G, Ahluwalia A. Microfabrication for tissue engineering: rethinking the cells-on-a scaffold approach. J Mater Chem. 2007;17(13):1248–54.
20. Seidi A et al. Gradient biomaterials for soft-to-hard interface tissue engineering. Acta Biomater. 2011;7(4):1441–51. This review focusess on fabrication techniques for generating gradient biomaterials. It explores specific experimental examples of gradient tissue engineering from soft tissues (e.g. cartilage) to hard tissues (e.g. bone).
21. Loh QL, Choong C. Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size. Tissue Eng B Rev. 2013;19(6):485–502. This review focuses on fabrication techniques for generating different pore sizes, porosity, and graded porous networks. It also evaluates how scaffold pore size and porosity directs cellular responses and the resulting mechanical properties.
22. Wray LS et al. A silk-based scaffold platform with tunable architecture for engineering critically-sized tissue constructs. Biomaterials. 2012;33(36):9214–24.
23. Radisic M et al. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng. 2006;12(8):2077–91.
24. Nazhat SN et al. Controlled microchannelling in dense collagen scaffolds by soluble phosphate glass fibers. Biomacromolecules. 2007;8(2):543–51.
25. Bagnaninchi PO et al. Chitosan microchannel scaffolds for tendon tissue engineering characterized using optical coherence tomography. Tissue Eng. 2007;13(2):323–31.
26. Moore MJ et al. Multiple-channel scaffolds to promote spinal cord axon regeneration. Biomaterials. 2006;27(3):419–29.
27. Zheng Y et al. In vitro microvessels for the study of angiogenesis and thrombosis. Proc Natl Acad Sci U S A. 2012;109(24):9342–7.
28. Morgan JP et al. Formation of microvascular networks in vitro. Nat Protoc. 2013;8(9):1820–36.
29. Schimek K et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13(18):3588–98.
30. Tiruvannamalai-Annamalai R, Armant DR, Matthew HW. A glycosaminoglycan based, modular tissue scaffold system for rapid assembly of perfusable, high cell density, engineered tissues. PLoS One. 2014;9(1):e84287.
31. Chwalek K et al. Glycosaminoglycan-based hydrogels to modulate heterocellular communication in in vitro angiogenesis models. Sci Rep. 2014;4:4414.
32. Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials. 2000;21(24):2529–43.
33. Vert M et al. Bioresorbability and biocompatibility of aliphatic polyesters. J Mater Sci Mater Med. 1992;3(6):432–46.
34. Stringa E et al. Collagen degradation and platelet-derived growth factor stimulate the migration of vascular smooth muscle cells. J Cell Sci. 2000;113(11):2055–64.
35. Wu G et al. Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells. J Am Chem Soc. 2008;130(26):8175–7.
36. Nazemi A, Schon TB, Gillies ER. Synthesis and degradation of backbone photodegradable polyester dendrimers. Org Lett. 2013;15(8):1830–3. This article demonstrates a well-defined, fully photodegradable material suited for triggerable biological degradation.
37. Epstein-Barash H et al. A microcomposite hydrogel for repeated on-demand ultrasound-triggered drug delivery. Biomaterials. 2010;31(19):5208–17.
38. Kost J, Leong K, Langer R. Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc Natl Acad Sci U S A. 1989;86(20):7663–6.
39. Fu HL et al. Collagenase-labile polyurethane urea synthesis and processing into hollow fiber membranes. Biomacromolecules. 2014;15(8):2924–32.
40. Lutolf MP et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci U S A. 2003;100(9):5413–8.
41. El-Sayed ME, Hoffman AS, Stayton PS. Rational design of composition and activity correlations for pH-responsive and glutathione-reactive polymer therapeutics. J Control Release. 2005;104(2):417–27.
42. Rufaihah AJ, Seliktar D. Hydrogels for therapeutic cardiovascular angiogenesis. Adv Drug Deliv Rev. 2015;96:31–9.
43. Babensee JE, McIntire LV, Mikos AG. Growth factor delivery for tissue engineering. Pharm Res. 2000;17(5):497–504.
44. Yang Y et al. Nerve conduits based on immobilization of nerve growth factor onto modified chitosan by using genipin as a crosslinking agent. Eur J Pharm Biopharm. 2011;79(3):519–25.
45. Coburn JM, Na E, Kaplan DL. Modulation of vincristine and doxorubicin binding and release from silk films. J Control Release. 2015;220(Pt A):229–38.
46. Pritchard EM, Kaplan DL. Silk fibroin biomaterials for controlled release drug delivery. Expert Opin Drug Deliv. 2011;8(6):797–811.
47. Coburn JM, Kaplan DL. Engineering biomaterial-drug conjugates for local and sustained chemotherapeutic delivery. Bioconjug Chem. 2015;26(7):1212–23.
48. Ma C et al. Hierarchical nanofibrous microspheres with controlled growth factor delivery for bone regeneration. Adv Healthc Mater. 2015;4:2699–708.
49. Zhu J et al. A tubular gelatin scaffold capable of the time-dependent controlled release of epidermal growth factor and mitomycin C. Colloids Surf B: Biointerfaces. 2015;135:416–24.
50. Li H et al. Spray-painted human fibronectin coating as an effective strategy to enhance graft ligamentization of a polyethylene terephthalate artificial ligament. Biotechnol Lett. 2014;36(5):1079–88.
51. Sharifiaghdas F et al. Comparing supportive properties of poly lactic-co-glycolic acid (PLGA), PLGA/collagen and human amniotic membrane for human urothelial and smooth muscle cells engineering. Urol J. 2014;11(3):1620–8.
52. Lee DY et al. Synergistic effect of laminin and mesenchymal stem cells on tracheal mucosal regeneration. Biomaterials. 2015;44:134–42.
53. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;12:697–715.
54. Williams C et al. Cardiac extracellular matrix-fibrin hybrid scaffolds with tunable properties for cardiovascular tissue engineering. Acta Biomater. 2015;14:84–95. This article demonstrates an example of a hybrid scaffold. An extracellular matrix / fibrin scaffold was generated that explores the effects of exploiting both composition and mechanical properties to control the differentiation of vascular and cardiac components.